Transplantation Drug Development Pipeline Review, 2017 - Product Image

Transplantation Drug Development Pipeline Review, 2017

  • ID: 4327949
  • Report
  • Region: Global
  • 242 Pages
  • GBI Research
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Capricor Therapeutics Inc
  • Escape Therapeutics Inc
  • Kiadis Pharma NV
  • OncoImmune Inc
  • Seres Therapeutics Inc
  • MORE

Summary

This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for graft-versus-host disease (GVHD), and the rejection of bone, liver, kidney, lung and heart transplants.

Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient's body. There are a total of 121 products in development for this indication, by 83 companies and 21 academic institutions. Key companies operating in this pipeline space include Novartis and Abbvie.

GVHD is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. There are a total of 108 products in development for this indication, by 76 companies and 19 academic institutions. Similarly to the bone marrow transplantation space, key companies operating in this pipeline space include Novartis and Abbvie.

Following a liver transplant, the immune system may consider the transplanted liver as foreign and may work against it. Patients may hence develop complications and ultimately reject the new organ. There are a total of ten products in development for this indication, by seven companies and two academic institutions.

Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Risk factors associated with transplantation are bleeding, infection, blockage of the blood vessels to the new kidney, leakage of urine or blockage of urine in the ureter and initial lack of function of the new kidney. There are a total of 39 products in development for this indication, by 33 companies and two academic institutions. Key companies operating in this pipeline space include Astellas, GlaxoSmithKline, Hillhurst Biopharmaceuticals and Kyowa Hakko Kirin.

Lung transplantation is a therapy used in various lung diseases. Lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. There are a total of ten products in development for this indication, by eight companies. Key companies operating in this pipeline space include Quark Pharmaceuticals and Radikal Therapeutics, both of which are fielding two products in this area each.

Finally, heart transplantation is a therapy used in various heart diseases. Heart transplant replaces an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted heart as foreign and may work against it. There are a total of seven products in development for this indication, all of which are in the Preclinical stage, by five companies, Of these products, Astellas are fielding three.

A wide range of targets, including integrins, chemokine receptors, protein kinases and cadherins are being developed, with no particular class of target predominating in terms of pipeline volume. However, there is a clear trend towards immune system molecular targets being studied, reflecting the underlying immune-based pathophysiology of these indications.

Scope

  • Which companies are the most active within the pipeline for transplantation therapeutics?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in the field of transplantation therapeutics?

Reasons to buy

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Capricor Therapeutics Inc
  • Escape Therapeutics Inc
  • Kiadis Pharma NV
  • OncoImmune Inc
  • Seres Therapeutics Inc
  • MORE

1. Research Report Guidance

2. Executive Summary

3. Introduction

4. Transplantation Report Coverage

  • Bone Marrow Transplant Rejection - Overview
  • Graft Versus Host Disease (GVHD) - Overview
  • Liver Transplant Rejection - Overview
  • Kidney Transplant Rejection - Overview
  • Lung Transplant Rejection - Overview
  • Heart Transplant Rejection - Overview

5. Therapeutics Development

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection
  • Lung Transplant Rejection
  • Heart Transplant Rejection

6. Therapeutics Assessment

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection
  • Lung Transplant Rejection
  • Heart Transplant Rejection

7. Companies Involved in Therapeutics Development

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection
  • Lung Transplant Rejection
  • Heart Transplant Rejection

8. Dormant Projects

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection
  • Lung Transplant Rejection
  • Heart Transplant Rejection

9. Discontinued Products

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection

10. Product Development Milestones

  • Bone Marrow Transplant Rejection
  • Graft Versus Host Disease (GVHD)
  • Liver Transplant Rejection
  • Kidney Transplant Rejection
  • Lung Transplant Rejection

11. Appendix

  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

List of Tables

  • Number of Products under Development for Bone Marrow Transplant Rejection
  • Number of Products under Development by Companies, Bone Marrow Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection
  • Products under Development by Companies, Bone Marrow Transplant Rejection
  • Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection
  • Number of Products under Development for Graft Versus Host Disease (GVHD)
  • Number of Products under Development by Companies, Graft Versus Host Disease (GVHD)
  • Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)
  • Products under Development by Companies, Graft Versus Host Disease (GVHD)
  • Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)
  • Number of Products under Development for Liver Transplant Rejection
  • Number of Products under Development by Companies, Liver Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Liver Transplant Rejection
  • Products under Development by Companies, Liver Transplant Rejection
  • Products under Development by Universities/Institutes, Liver Transplant Rejection
  • Number of Products under Development for Kidney Transplant Rejection
  • Number of Products under Development by Companies, Kidney Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection
  • Products under Development by Companies, Kidney Transplant Rejection
  • Products under Development by Universities/Institutes, Kidney Transplant Rejection
  • Number of Products under Development for Lung Transplant Rejection
  • Number of Products under Development by Companies, Lung Transplant Rejection
  • Products under Development by Companies, Lung Transplant Rejection
  • Number of Products under Development for Heart Transplant Rejection
  • Number of Products under Development by Companies, Heart Transplant Rejection
  • Products under Development by Companies, Heart Transplant Rejection
  • Number of Products by Stage and Target, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Mechanism of Action, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Route of Administration, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Molecule Type, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Target, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Mechanism of Action, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Route of Administration, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Molecule Type, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Target, Liver Transplant Rejection
  • Number of Products by Stage and Mechanism of Action, Liver Transplant Rejection
  • Number of Products by Stage and Route of Administration, Liver Transplant Rejection
  • Number of Products by Stage and Molecule Type, Liver Transplant Rejection
  • Number of Products by Stage and Target, Kidney Transplant Rejection
  • Number of Products by Stage and Mechanism of Action, Kidney Transplant Rejection
  • Number of Products by Stage and Route of Administration, Kidney Transplant Rejection
  • Number of Products by Stage and Molecule Type, Kidney Transplant Rejection
  • Number of Products by Stage and Target, Lung Transplant Rejection
  • Number of Products by Stage and Mechanism of Action, Lung Transplant Rejection
  • Number of Products by Stage and Route of Administration, Lung Transplant Rejection
  • Number of Products by Stage and Molecule Type, Lung Transplant Rejection
  • Number of Products by Stage and Target, Heart Transplant Rejection
  • Number of Products by Stage and Mechanism of Action, Heart Transplant Rejection
  • Number of Products by Stage and Route of Administration, Heart Transplant Rejection
  • Number of Products by Stage and Molecule Type, Heart Transplant Rejection
  • Bone Marrow Transplant Rejection - Pipeline by AbbVie Inc
  • Bone Marrow Transplant Rejection - Pipeline by AbGenomics International Inc
  • Bone Marrow Transplant Rejection - Pipeline by Actelion Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Alexion Pharmaceuticals Inc
  • Bone Marrow Transplant Rejection - Pipeline by Allergan Plc
  • Bone Marrow Transplant Rejection - Pipeline by Amunix Operating Inc
  • Bone Marrow Transplant Rejection - Pipeline by AnaptysBio Inc
  • Bone Marrow Transplant Rejection - Pipeline by apceth Biopharma GmbH
  • Bone Marrow Transplant Rejection - Pipeline by Aptevo Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by arGEN-X BV
  • Bone Marrow Transplant Rejection - Pipeline by Athersys Inc
  • Bone Marrow Transplant Rejection - Pipeline by Bellicum Pharmaceuticals Inc
  • Bone Marrow Transplant Rejection - Pipeline by Bio-Cancer Treatment International Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Biogen Inc
  • Bone Marrow Transplant Rejection - Pipeline by Bristol-Myers Squibb Company
  • Bone Marrow Transplant Rejection - Pipeline by Cantex Pharmaceuticals Inc
  • Bone Marrow Transplant Rejection - Pipeline by Capricor Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Cell Source Inc
  • Bone Marrow Transplant Rejection - Pipeline by Cell2B Advanced Therapeutics SA
  • Bone Marrow Transplant Rejection - Pipeline by CellECT Bio Inc
  • Bone Marrow Transplant Rejection - Pipeline by Cleveland BioLabs Inc
  • Bone Marrow Transplant Rejection - Pipeline by Compugen Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Cynata Therapeutics Limited
  • Bone Marrow Transplant Rejection - Pipeline by Cytodyn Inc
  • Bone Marrow Transplant Rejection - Pipeline by Dompe Farmaceutici SpA
  • Bone Marrow Transplant Rejection - Pipeline by Dr. Falk Pharma GmbH
  • Bone Marrow Transplant Rejection - Pipeline by Escape Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by F. Hoffmann-La Roche Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Fate Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Generon (Shanghai) Corp Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Gilead Sciences Inc
  • Bone Marrow Transplant Rejection - Pipeline by GlaxoSmithKline Plc
  • Bone Marrow Transplant Rejection - Pipeline by Immunomedics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Incyte Corp
  • Bone Marrow Transplant Rejection - Pipeline by Jazz Pharmaceuticals Plc
  • Bone Marrow Transplant Rejection - Pipeline by Kadmon Corp LLC
  • Bone Marrow Transplant Rejection - Pipeline by Kamada Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Kiadis Pharma NV
  • Bone Marrow Transplant Rejection - Pipeline by Kymab Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Kyorin Pharmaceutical Co Ltd
  • Bone Marrow Transplant Rejection - Pipeline by MacroGenics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Mallinckrodt Plc
  • Bone Marrow Transplant Rejection - Pipeline by Medsenic
  • Bone Marrow Transplant Rejection - Pipeline by Mesoblast Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Millennium Pharmaceuticals Inc
  • Bone Marrow Transplant Rejection - Pipeline by Nektar Therapeutics
  • Bone Marrow Transplant Rejection - Pipeline by Neovii Pharmaceuticals AG
  • Bone Marrow Transplant Rejection - Pipeline by Nohla Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Novartis AG
  • Bone Marrow Transplant Rejection - Pipeline by OncoImmune Inc
  • Bone Marrow Transplant Rejection - Pipeline by OSE Immunotherapeutics
  • Bone Marrow Transplant Rejection - Pipeline by Pfizer Inc
  • Bone Marrow Transplant Rejection - Pipeline by Pharmicell Co Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Pluristem Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by REGiMMUNE Corp
  • Bone Marrow Transplant Rejection - Pipeline by Sanofi
  • Bone Marrow Transplant Rejection - Pipeline by Sarepta Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Seattle Genetics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Seres Therapeutics Inc
  • Bone Marrow Transplant Rejection - Pipeline by Sigmoid Pharma Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Synedgen Inc
  • Bone Marrow Transplant Rejection - Pipeline by Taiga Biotechnologies Inc
  • Bone Marrow Transplant Rejection - Pipeline by Takeda Pharmaceutical Company Ltd
  • Bone Marrow Transplant Rejection - Pipeline by Targazyme Inc
  • Bone Marrow Transplant Rejection - Pipeline by United BioPharma Inc
  • Bone Marrow Transplant Rejection - Pipeline by Vault Pharma Inc
  • Bone Marrow Transplant Rejection - Pipeline by VBI Vaccines Inc
  • Bone Marrow Transplant Rejection - Pipeline by Xenikos BV
  • Bone Marrow Transplant Rejection - Pipeline by XL-protein GmbH
  • Bone Marrow Transplant Rejection - Pipeline by ZIOPHARM Oncology Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by AbbVie Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by AbGenomics International Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Allergan Plc
  • Graft Versus Host Disease (GVHD) - Pipeline by Amunix Operating Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by AnaptysBio Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by apceth Biopharma GmbH
  • Graft Versus Host Disease (GVHD) - Pipeline by Aptevo Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by arGEN-X BV
  • Graft Versus Host Disease (GVHD) - Pipeline by Athersys Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Bellicum Pharmaceuticals Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Bio-Cancer Treatment International Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Biogen Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Bristol-Myers Squibb Company
  • Graft Versus Host Disease (GVHD) - Pipeline by Capricor Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Cell2B Advanced Therapeutics SA
  • Graft Versus Host Disease (GVHD) - Pipeline by CellECT Bio Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Commence Bio Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Cynata Therapeutics Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Cytodyn Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Dr. Falk Pharma GmbH
  • Graft Versus Host Disease (GVHD) - Pipeline by Escape Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by F. Hoffmann-La Roche Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Fate Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Generon (Shanghai) Corp Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Gilead Sciences Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by GlaxoSmithKline Plc
  • Graft Versus Host Disease (GVHD) - Pipeline by Incyte Corp
  • Graft Versus Host Disease (GVHD) - Pipeline by Jazz Pharmaceuticals Plc
  • Graft Versus Host Disease (GVHD) - Pipeline by Kadmon Corp LLC
  • Graft Versus Host Disease (GVHD) - Pipeline by Kamada Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Kiadis Pharma NV
  • Graft Versus Host Disease (GVHD) - Pipeline by Kymab Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Kyorin Pharmaceutical Co Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by MacroGenics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Mallinckrodt Plc
  • Graft Versus Host Disease (GVHD) - Pipeline by Mesoblast Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Millennium Pharmaceuticals Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Nektar Therapeutics
  • Graft Versus Host Disease (GVHD) - Pipeline by Nohla Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Novartis AG
  • Graft Versus Host Disease (GVHD) - Pipeline by OncoImmune Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by OSE Immunotherapeutics
  • Graft Versus Host Disease (GVHD) - Pipeline by Pfizer Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Pharmicell Co Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by REGiMMUNE Corp
  • Graft Versus Host Disease (GVHD) - Pipeline by Sanofi
  • Graft Versus Host Disease (GVHD) - Pipeline by Sarepta Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Seattle Genetics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Seres Therapeutics Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Sigmoid Pharma Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Synedgen Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Takeda Pharmaceutical Company Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by Targazyme Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by TC BioPharm Ltd
  • Graft Versus Host Disease (GVHD) - Pipeline by TxCell SA
  • Graft Versus Host Disease (GVHD) - Pipeline by United BioPharma Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Vault Pharma Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by VBI Vaccines Inc
  • Graft Versus Host Disease (GVHD) - Pipeline by Xenikos BV
  • Graft Versus Host Disease (GVHD) - Pipeline by XL-protein GmbH
  • Graft Versus Host Disease (GVHD) - Pipeline by ZIOPHARM Oncology Inc
  • Liver Transplant Rejection - Pipeline by Astellas Pharma Inc
  • Liver Transplant Rejection - Pipeline by Biogen Inc
  • Liver Transplant Rejection - Pipeline by Conatus Pharmaceuticals Inc
  • Liver Transplant Rejection - Pipeline by Dompe Farmaceutici SpA
  • Liver Transplant Rejection - Pipeline by Novartis AG
  • Liver Transplant Rejection - Pipeline by RedHill Biopharma Ltd
  • Kidney Transplant Rejection - Pipeline by Amgen Inc
  • Kidney Transplant Rejection - Pipeline by Angion Biomedica Corp
  • Kidney Transplant Rejection - Pipeline by Apellis Pharmaceuticals Inc
  • Kidney Transplant Rejection - Pipeline by Astellas Pharma Inc
  • Kidney Transplant Rejection - Pipeline by Biogen Inc
  • Kidney Transplant Rejection - Pipeline by Catalyst Biosciences Inc
  • Kidney Transplant Rejection - Pipeline by Corline Biomedical AB
  • Kidney Transplant Rejection - Pipeline by CSL Ltd
  • Kidney Transplant Rejection - Pipeline by GlaxoSmithKline Plc
  • Kidney Transplant Rejection - Pipeline by Grifols SA
  • Kidney Transplant Rejection - Pipeline by Hansa Medical AB
  • Kidney Transplant Rejection - Pipeline by Kyowa Hakko Kirin Co Ltd
  • Kidney Transplant Rejection - Pipeline by Magnus Life Ltd
  • Kidney Transplant Rejection - Pipeline by Noorik Biopharmaceuticals AG
  • Kidney Transplant Rejection - Pipeline by Novartis AG
  • Kidney Transplant Rejection - Pipeline by Opsona Therapeutics Ltd
  • Kidney Transplant Rejection - Pipeline by OSE Immunotherapeutics
  • Kidney Transplant Rejection - Pipeline by Pharmicell Co Ltd
  • Kidney Transplant Rejection - Pipeline by Pharming Group NV
  • Kidney Transplant Rejection - Pipeline by Prolong Pharmaceuticals LLC
  • Kidney Transplant Rejection - Pipeline by Quark Pharmaceuticals Inc
  • Kidney Transplant Rejection - Pipeline by Shire Plc
  • Kidney Transplant Rejection - Pipeline by Tiziana Life Sciences Plc
  • Lung Transplant Rejection - Pipeline by Apeptico Forschung und Entwicklung GmbH
  • Lung Transplant Rejection - Pipeline by Dompe Farmaceutici SpA
  • Lung Transplant Rejection - Pipeline by Kamada Ltd
  • Lung Transplant Rejection - Pipeline by Novartis AG
  • Lung Transplant Rejection - Pipeline by Quark Pharmaceuticals Inc
  • Heart Transplant Rejection - Pipeline by Astellas Pharma Inc
  • Heart Transplant Rejection - Pipeline by Heat Biologics Inc
  • Heart Transplant Rejection - Pipeline by Noxxon Pharma AG
  • Bone Marrow Transplant Rejection - Dormant Projects
  • Graft Versus Host Disease (GVHD) - Dormant Projects
  • Liver Transplant Rejection - Dormant Projects
  • Kidney Transplant Rejection - Dormant Projects
  • Lung Transplant Rejection - Dormant Projects
  • Heart Transplant Rejection - Dormant Projects
  • Bone Marrow Transplant Rejection - Discontinued Products
  • Graft Versus Host Disease (GVHD) - Discontinued Products
  • Liver Transplant Rejection - Discontinued Products
  • Kidney Transplant Rejection - Discontinued Products

List of Figures

  • Number of Products under Development for Bone Marrow Transplant Rejection
  • Number of Products under Development by Companies, Bone Marrow Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection
  • Number of Products under Development for Graft Versus Host Disease (GVHD)
  • Number of Products under Development by Companies, Graft Versus Host Disease (GVHD)
  • Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)
  • Number of Products under Development for Liver Transplant Rejection
  • Number of Products under Development by Companies, Liver Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Liver Transplant Rejection
  • Number of Products under Development for Kidney Transplant Rejection
  • Number of Products under Development by Companies, Kidney Transplant Rejection
  • Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection
  • Number of Products under Development for Lung Transplant Rejection
  • Number of Products under Development by Companies, Lung Transplant Rejection
  • Number of Products by Top 10 Targets, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Top 10 Targets, Bone Marrow Transplant Rejection
  • Number of Products by Top 10 Mechanism of Actions, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Top 10 Mechanism of Actions, Bone Marrow Transplant Rejection
  • Number of Products by Routes of Administration, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Bone Marrow Transplant Rejection
  • Number of Products by Top 10 Molecule Types, Bone Marrow Transplant Rejection
  • Number of Products by Stage and Top 10 Molecule Types, Bone Marrow Transplant Rejection
  • Number of Products by Top 10 Targets, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Top 10 Targets, Graft Versus Host Disease (GVHD)
  • Number of Products by Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD)
  • Number of Products by Routes of Administration, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Routes of Administration, Graft Versus Host Disease (GVHD)
  • Number of Products by Top 10 Molecule Types, Graft Versus Host Disease (GVHD)
  • Number of Products by Stage and Top 10 Molecule Types, Graft Versus Host Disease (GVHD)
  • Number of Products by Top 10 Targets, Liver Transplant Rejection
  • Number of Products by Stage and Top 10 Targets, Liver Transplant Rejection
  • Number of Products by Top 10 Mechanism of Actions, Liver Transplant Rejection
  • Number of Products by Stage and Top 10 Mechanism of Actions, Liver Transplant Rejection
  • Number of Products by Routes of Administration, Liver Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Liver Transplant Rejection
  • Number of Products by Molecule Types, Liver Transplant Rejection
  • Number of Products by Stage and Molecule Types, Liver Transplant Rejection
  • Number of Products by Top 10 Targets, Kidney Transplant Rejection
  • Number of Products by Stage and Top 10 Targets, Kidney Transplant Rejection
  • Number of Products by Top 10 Mechanism of Actions, Kidney Transplant Rejection
  • Number of Products by Stage and Top 10 Mechanism of Actions, Kidney Transplant Rejection
  • Number of Products by Routes of Administration, Kidney Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Kidney Transplant Rejection
  • Number of Products by Top 10 Molecule Types, Kidney Transplant Rejection
  • Number of Products by Stage and Top 10 Molecule Types, Kidney Transplant Rejection
  • Number of Products by Targets, Lung Transplant Rejection
  • Number of Products by Stage and Targets, Lung Transplant Rejection
  • Number of Products by Top 10 Mechanism of Actions, Lung Transplant Rejection
  • Number of Products by Stage and Top 10 Mechanism of Actions, Lung Transplant Rejection
  • Number of Products by Routes of Administration, Lung Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Lung Transplant Rejection
  • Number of Products by Molecule Types, Lung Transplant Rejection
  • Number of Products by Stage and Molecule Types, Lung Transplant Rejection
  • Number of Products by Targets, Heart Transplant Rejection
  • Number of Products by Stage and Targets, Heart Transplant Rejection
  • Number of Products by Mechanism of Actions, Heart Transplant Rejection
  • Number of Products by Stage and Mechanism of Actions, Heart Transplant Rejection
  • Number of Products by Routes of Administration, Heart Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Heart Transplant Rejection
  • Number of Products by Molecule Types, Heart Transplant Rejection
  • Number of Products by Stage and Routes of Administration, Heart Transplant Rejection
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AbGenomics International Inc
  • AbbVie Inc
  • Actelion Ltd
  • Alexion Pharmaceuticals Inc
  • Allergan Plc
  • Amgen Inc
  • Amunix Operating Inc
  • AnaptysBio Inc
  • Angion Biomedica Corp
  • Apceth Biopharma GmbH
  • Apellis Pharmaceuticals Inc
  • Apeptico Forschung und Entwicklung GmbH
  • Aptevo Therapeutics Inc
  • ArGEN-X BV
  • Astellas Pharma Inc
  • Athersys Inc
  • Bellicum Pharmaceuticals Inc
  • Bio-Cancer Treatment International Ltd
  • Biogen Inc
  • Bristol-Myers Squibb Company
  • CSL Ltd
  • Cantex Pharmaceuticals Inc
  • Capricor Therapeutics Inc
  • Catalyst Biosciences Inc
  • Cell Source Inc
  • Cell2B Advanced Therapeutics SA
  • CellECT Bio Inc
  • Cleveland BioLabs Inc
  • Commence Bio Inc
  • Compugen Ltd
  • Conatus Pharmaceuticals Inc
  • Corline Biomedical AB
  • Cynata Therapeutics Limited
  • Cynata Therapeutics Ltd
  • Cytodyn Inc
  • Dompe Farmaceutici SpA
  • Dr. Falk Pharma GmbH
  • Escape Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Fate Therapeutics Inc
  • Generon (Shanghai) Corp Ltd
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Grifols SA
  • Hansa Medical AB
  • Heat Biologics Inc
  • Immunomedics Inc
  • Incyte Corp
  • Jazz Pharmaceuticals Plc
  • Kadmon Corp LLC
  • Kamada Ltd
  • Kiadis Pharma NV
  • Kymab Ltd
  • Kyorin Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • MacroGenics Inc
  • Magnus Life Ltd
  • Mallinckrodt Plc
  • Medsenic
  • Mesoblast Ltd
  • Millennium Pharmaceuticals Inc
  • Nektar Therapeutics
  • Neovii Pharmaceuticals AG
  • Nohla Therapeutics Inc
  • Noorik Biopharmaceuticals AG
  • Novartis AG
  • Noxxon Pharma AG
  • OSE Immunotherapeutics
  • OncoImmune Inc
  • Opsona Therapeutics Ltd
  • Pfizer Inc
  • Pharmicell Co Ltd
  • Pharming Group NV
  • Pluristem Therapeutics Inc
  • Prolong Pharmaceuticals LLC
  • Quark Pharmaceuticals Inc
  • Quark Pharmaceuticals Inc
  • REGiMMUNE Corp
  • RedHill Biopharma Ltd
  • Sanofi
  • Sarepta Therapeutics Inc
  • Seattle Genetics Inc
  • Seres Therapeutics Inc
  • Shire Plc
  • Sigmoid Pharma Ltd
  • Synedgen Inc
  • TC BioPharm Ltd
  • Taiga Biotechnologies Inc
  • Takeda Pharmaceutical Company Ltd
  • Targazyme Inc
  • Tiziana Life Sciences Plc
  • TxCell SA
  • United BioPharma Inc
  • VBI Vaccines Inc
  • Vault Pharma Inc
  • XL-protein GmbH
  • Xenikos BV
  • ZIOPHARM Oncology Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll